AR126473A1 - Derivados de 6h-imidazo[1,2-a]pirrolo[2,3-e]piridina para su uso en terapia - Google Patents

Derivados de 6h-imidazo[1,2-a]pirrolo[2,3-e]piridina para su uso en terapia

Info

Publication number
AR126473A1
AR126473A1 ARP220101871A ARP220101871A AR126473A1 AR 126473 A1 AR126473 A1 AR 126473A1 AR P220101871 A ARP220101871 A AR P220101871A AR P220101871 A ARP220101871 A AR P220101871A AR 126473 A1 AR126473 A1 AR 126473A1
Authority
AR
Argentina
Prior art keywords
compound
formula
cancer
alkyl group
group
Prior art date
Application number
ARP220101871A
Other languages
English (en)
Spanish (es)
Inventor
Aline Moulin
Jean-Franois Peyronel
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of AR126473A1 publication Critical patent/AR126473A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP220101871A 2021-07-16 2022-07-15 Derivados de 6h-imidazo[1,2-a]pirrolo[2,3-e]piridina para su uso en terapia AR126473A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21306000 2021-07-16

Publications (1)

Publication Number Publication Date
AR126473A1 true AR126473A1 (es) 2023-10-11

Family

ID=77126713

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220101871A AR126473A1 (es) 2021-07-16 2022-07-15 Derivados de 6h-imidazo[1,2-a]pirrolo[2,3-e]piridina para su uso en terapia

Country Status (7)

Country Link
US (1) US20240294529A1 (enExample)
EP (1) EP4370516A1 (enExample)
JP (1) JP2024525792A (enExample)
CN (1) CN118234727A (enExample)
AR (1) AR126473A1 (enExample)
TW (1) TW202320753A (enExample)
WO (1) WO2023285465A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117916240A (zh) 2021-07-16 2024-04-19 赛诺菲 用于疗法的咪唑并[1,2-b][1,2,4]三唑衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2906250B1 (fr) * 2006-09-22 2008-10-31 Sanofi Aventis Sa Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
FR2925902B1 (fr) * 2008-01-02 2011-01-07 Sanofi Aventis DERIVES D'IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2928922B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
FR2928924B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
FR2928923B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
FR2950344B1 (fr) * 2009-09-18 2011-11-25 Sanofi Aventis Derives de 5-phenyl-pyrazolopyridine, leur preparation et leur aplication en therapeutique.
US20220016073A1 (en) * 2017-11-15 2022-01-20 Korea Research Institute Of Bioscience And Biotechnology Composition for preventing or treating neurodegenerative diseases, containing diterpene-based compound

Also Published As

Publication number Publication date
WO2023285465A1 (en) 2023-01-19
EP4370516A1 (en) 2024-05-22
US20240294529A1 (en) 2024-09-05
CN118234727A (zh) 2024-06-21
JP2024525792A (ja) 2024-07-12
TW202320753A (zh) 2023-06-01

Similar Documents

Publication Publication Date Title
KR102939341B1 (ko) 오로라 키나아제 억제제 및 이의 용도
KR102702618B1 (ko) 면역조절제
KR100191193B1 (ko) 6환 화합물
AU2016248366B2 (en) Heterocycles useful as IDO and TDO inhibitors
CN108948004B (zh) 作为fgfr4抑制剂的杂环化合物
MX390577B (es) Proceso de preparación de n-(5-(3-(7-(3-fluorofenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)-3-metilbutanamida.
JP2016512823A5 (enExample)
EA027139B1 (ru) Замещенные 5-(3,5-диметилизоксазол-4-ил)индолин-2-оны
WO2019214681A1 (en) Heteroaryl compounds and uses thereof
EP3676264A1 (en) Pikfyve kinase inhibitors
EA018945B1 (ru) Производные азакарболинов, способ их получения и применение в терапии
CN105622709A (zh) 丹参酮i衍生物及其制备方法和应用
JP4707393B2 (ja) 抗癌化合物
US9416142B2 (en) Griseofulvin derivatives
Barbero et al. An efficient copper-catalytic system for performing intramolecular O-arylation reactions in aqueous media. New synthesis of xanthones
EP2595972A1 (en) Tricyclic lactones for treatment of cancer
US12291531B2 (en) Matrine α-ketoamine compounds, preparation method therefor and use thereof
CN114616234B (zh) 磷咪唑并喹啉胺衍生物、及其药物组合物和应用
JP2014527508A5 (enExample)
AR121666A1 (es) DERIVADOS DE NAFTIRIDINA Y PIRIDO[3,4-C]PIRIDAZINA COMO MODULADORES DEL RECEPTOR GABAA a5
CN102124010A (zh) 具有血管舒张活性的硝酸异山梨酯
MXPA04011682A (es) Camptotecinas con un anillo lactona modificado.
RU2230745C2 (ru) Оптически чистые аналоги камптотецина
JP2024525792A5 (enExample)
KR102678127B1 (ko) 신규한 퀴논 유도체

Legal Events

Date Code Title Description
FA Abandonment or withdrawal